No Detail Found!

Association of TGF-β1 with cystatin-C in patients with diabetic nephropathy

Author(s)
Ali Hassan Jasem Al-Faiha'a Teaching Hospital,Basra,Iraq
Nazar S. Haddad Iraqi Board of Medical Specializations In Clinical Chemistry (FIBMS. Chem. Path.), American Association for Clinical Chemistry (FAACC), College of Medicine, University of Basrah,Basrah,Iraq
Nassar Taha Yaseen Department of Endocrinology, Faiha Specialized Diabetes, Endocrine and Metabolism Center,FDEMC,
Abstract
Background & Objective: Diabetes is considered a condition that is characterized by an increase in oxidative stress and inflammation. Transforming growth factor-beta (TGF-ß) belongs to the TGF-ß subfamily of the TGF-ß superfamily. Numerous biological processes, such as cell growth, differentiation, adhesion, proliferation, tissue repair, morphogenesis, and apoptosis, are regulated by the TGF-ß subfamily. Five TGF-ß isoforms in this subfamily have been found in vertebrates; however, only TGF-ß 1-3 has been demonstrated to be expressed in mammals. Methodology: The current research comprised of a total of 130 individuals, all of whom were placed into one of three primary groups ; 50 (25 males and 25 females) diabetic patients without nephropathy; 50 (25 males and 25 females) diabetic patients with nephropathy as cases, and 30 (15 males and 15 females) persons in good health, who were of the same age as the patients being studied. In order to measure the concentrations of the parameters, the standard procedures and techniques were used. Results: The mean value of serum TGF-ß1was significantly higher in diabetic patients without nephropathy and diabetic patients with nephropathy (40.19 ± 3.56 ng/ml),(51.21 ± 5.20 ng/ml) respectively as compared to controls (24.80 ± 3.51 ng/ml) with a high significant difference (P 0.05), which may be due to the fact that the level of TGF 1 rises with increasing duration of the participant's cases. Conclusion: There is no significant correlation between cystatin-C with fasting blood sugar. There was a statistically significant and positive link between the blood TGF-ß1 levels and the serum creatinine and cystatin-C levels.
Publication Details
Page(s) 151-154
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 28, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
TGF-ß1, Type-2 diabetes mellitus, Cystatin-C
References
Saeedi P,Petersohn I,Salpea P,Malanda B,Karuranga S,Unwin N .2019 .Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract, 157 : 107843.
Teixeira-Lemos E,Nunes S,Teixeira F .2011 .Regular physical exercise training assists in preventing type 2 diabetes develop ment: focus on its antioxidant and anti-inflammatory properties. Cardiovasc Diabetol, 10 : 12.
Berbudi A,Rahmadika N,Tjahjadi AI,Ruslami R .2020 .Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev, 16 : 442-9.
Wrighton K.H.,Lin X.,Feng X.H. .2009 .Phospho-control of TGFbeta superfamily signaling. Cell Res, 19(1) : 8-20.
WHO .2017 .Diabetes fact sheet. , : .
Giacco F,Brownlee M. . .Oxidative stress and diabetic complications. 2010 Oct, 10(9) : PMC2996922-70.
Shaker YM,Soliman HA,Ezzat E,Hussein NS,Ashour E,Donia A,Eweida SM . .Serum and urinary transforming growth factor beta 1 as biochemical markers in diabetic nephropathy patients. , : .
Beni-Suef Univ J Basic Appl Sci .2014 .. , 3(1) : .
Jeon YL,Kim MH,Lee WI,Kang SY . .Cystatin C as an early marker of diabetic nephropathy in patients with type 2 diabetes.. , : .
Lab Clin .2013 .. , 24409655 : 1221-9.
Hills CE,Squires PE .2011 .The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine & Growth Factor Reviews, : .
Santibañez M.,Quintanilla C.,Bernabeu C. .2011 .TGFβ/TGF-β receptor system and its role in physiological and pathological conditions. Clinical Science, 121(6) : 233-251.
Pelton R.W. .1991 .Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol, 115(4) : 1091-105.
Hills C.E. and P.E.,Squires C.E. and P.E. .2010 .TGF-beta1-induced epithelial-tomesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol, 31(1) : 68-74.
Sharma K.,Ziyadeh F.N. .1997 .Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol, 17(2) : 80-92.
Wang W.,Koka V.,Lan H.Y. .2005 .Transforming growth factorbeta and Smad signalling in kidney diseases. Nephrology (Carlton), 10(1) : 48-56.
Sureshbabu A,Muhsin SA,Choi ME .2015 .Epub 2016 Jan 6. Am J Physiol Renal Physiol. 2016 Apr, 10(7) : PMC4824143-F606.
0

Citations

0

Downloads

44

Views